A global, top-10 pharma client sought Putnam’s guidance on developing a lean launch strategy for a novel cell therapy in oncology and how to best engage with customers given the small footprint of hospitals certified to administer cell therapy.
An emerging biotech sought Putnam’s guidance to design and execute the global commercialization of their asset for a rare oncology indication.
A rapidly shifting healthcare landscape and a wave of cost-containment initiatives destined to put further pressure on the pricing of pharmaceuticals across all major geographies (e.g., Inflation Reduction Act in the US and the recent pricing and reimbursement reform in Germany) is placing greater emphasis on optimized customer engagement models.
Scott Briggs, Principal, joined a live panel of industry experts to discuss the Inflation Reduction Act on March 30th. To listen to the recording, register now.
At this year’s sold-out Medical Affairs Professional Society (MAPS) Annual Meeting in Nashville, the evolution of Medical Affairs as a pivotal strategic leader at the intersection of clinical development and commercial was evident.
A clinical-stage biopharmaceutical company sought to develop an optimized portfolio strategy. It sought Putnam’s guidance to prioritize asset-level strategies through a holistic review of options.
With several other in-class competitors, a client sought Putnam’s guidance on a go/no-go development decision for a first-generation targeted therapy in Phase 1 clinical development.
At each stage of clinical development, Putnam helps biopharma companies answer questions that are critical to regulatory approval and commercial adoption.
Putnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.
